Journal Article Summary
The article investigates the effectiveness of two medications, semaglutide and liraglutide, in treating weight regain after metabolic and bariatric surgery (MBS). This topic is significant because many individuals who undergo MBS experience weight recurrence, which can lead to serious health issues such as type 2 diabetes and other obesity-related conditions. Understanding which medication is more effective can help healthcare providers better manage weight in patients who have had MBS, ultimately improving their long-term health outcomes.
In this study, researchers analyzed data from 207 adults who had experienced weight recurrence after MBS and were treated with either semaglutide (1.0 mg weekly) or liraglutide (3.0 mg daily) over a 12-month period. The results showed that patients taking semaglutide lost an average of 12.92% of their body weight, compared to an 8.77% loss for those on liraglutide, indicating that semaglutide was significantly more effective. Additionally, a higher percentage of patients on semaglutide achieved substantial weight loss milestones, such as losing 10% or more of their body weight.
Despite these promising findings, the study has limitations, including its retrospective design, which means it relied on existing health records and could not assess factors like medication adherence or side effects. Patients should consult their healthcare providers to discuss the best treatment options for managing weight after MBS, especially considering the potential for off-label use of medications and the need for personalized treatment plans. It is essential to address weight management as a chronic condition, and further research is needed to establish optimal strategies for preventing weight recurrence after MBS.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Murvelashvili Natia, Xie Luyu, Schellinger Jeffrey N., Mathew M. Sunil, Marroquin Elisa Morales, Lingvay Ildiko, Messiah Sarah E., Almandoz Jaime P.. Effectiveness of semaglutide versus liraglutide for treating post-metabolic and bariatric surgery weight recurrence. Obesity (Silver Spring, Md.) 2023. DOI: 10.1002/oby.23736. PMID: 36998152. PMCID: PMC12398307.
Featured Pill Pals Product
Semaglutide with B-12 --- 10 mg / 2 mg / 4 ml --- 4 ml vial --- Weight Loss Glucagon-Like Peptide-1 (GLP-1)
Semaglutide with B-12 — 10 mg / 2 mg / 4 ml — 4 ml vial — Weight Loss Glucagon-Like Peptide-1 (GLP-1) is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
